Design, synthesis & evaluation of human Aurora kinase and phosphodiesterase inhibitors for anti-trypanosomal drug discovery via target repurposing
Neglected tropical diseases (NTDs) represent a group of infectious diseases that blight the lives of approximately one billion people, and collectively cause around 550,000 deaths each year. These diseases are generally concentrated in low-income countries from Africa and Latin America, but are also...
Published: |
|
---|---|
Online Access: | http://hdl.handle.net/2047/d20002770 |
Similar Items
-
The pan-Aurora kinase inhibitor tozasertib as a repurposed drug for Mycn-amplified neuroblastoma
by: Chun-Li Hou, et al.
Published: (2016) -
Repurposing Phosphodiesterase-5 inhibitors as chemoadjuvants
by: Amit K. Tiwari, et al.
Published: (2013-06-01) -
Computationally-guided drug repurposing enables the discovery of kinase targets and inhibitors as new schistosomicidal agents.
by: Sandra Giuliani, et al.
Published: (2018-10-01) -
Phenotypic screening approaches to develop Aurora kinase inhibitors: Drug Discovery perspectives
by: Carlos eMarugán, et al.
Published: (2016-01-01) -
Development of Phosphodiesterase–Protein-Kinase Complexes as Novel Targets for Discovery of Inhibitors with Enhanced Specificity
by: Nikhil K. Tulsian, et al.
Published: (2021-05-01)